⚠ You're viewing a report from February 2025. Subscribe to get the latest →

FDA Enforcement — February 2025 Report

Automated analysis of 25 items from public government data sources. Updated daily.

Summary

25
Total items
15
High impact
10
Medium impact
0
Low impact

High-impact items this period

Granules India Limited
Manufacturing adulterated finished pharmaceutical products
Why: CGMP deviations in finished pharmaceutical manufacturing processes or materials  ·  Feb 26  ·  Impact: HIGH
TKTX Numbing Cream USA
Marketing unapproved new drug product as OTC
Why: Selling topical numbing product without FDA approval or proper drug classification  ·  Feb 25  ·  Impact: HIGH
TKTX USA
Unapproved new drug misbranded as OTC product
Why: Marketing unapproved pharmaceutical product without FDA approval  ·  Feb 25  ·  Impact: HIGH
TKTX Store
Marketing unapproved new drug product as OTC
Why: Selling topical numbing product without FDA approval or proper drug classification  ·  Feb 25  ·  Impact: HIGH
TKTX Numb Store
Marketing unapproved new drug product as OTC
Why: Selling topical numbing product without FDA approval or proper drug classification  ·  Feb 25  ·  Impact: HIGH
Sperm Bank, Inc. dba Fertility Center of California
HCT/P regulations and CFR deviations for cellular products
Why: Non-compliance with human cells, tissues, cellular products regulations  ·  Feb 14  ·  Impact: HIGH
Zenzi Pharmaceutical Industries Pvt. Ltd.
Refused FDA access to records and data copying
Why: Non-compliance with FDA inspection authority and record access requirements  ·  Feb 13  ·  Impact: HIGH
Chem-Tech, Ltd.
Finished pharmaceutical product adulteration CGMP violation
Why: Current Good Manufacturing Practice non-compliance in finished drug production  ·  Feb 11  ·  Impact: HIGH
ABR Laboratory LLC
Finished pharmaceutical product adulteration CGMP violation
Why: Current Good Manufacturing Practice non-compliance in finished drug production  ·  Feb 10  ·  Impact: HIGH
Marshalls Traditional Healthcare CC
Adulterated finished pharmaceutical CGMP violations
Why: Manufacturing process non-compliance in finished drug products  ·  Feb 10  ·  Impact: HIGH

Selected medium-impact items

The Vapor Club LLC
Tobacco product adulterated and misbranded violation
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act  ·  Feb 27  ·  Impact: MEDIUM
Elk River Vapor Shop
Tobacco product adulterated and misbranded violation
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act  ·  Feb 27  ·  Impact: MEDIUM
Loveli Design, LLC d/b/a Alice in Vapeland
Tobacco product adulterated and misbranded violation
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act  ·  Feb 21  ·  Impact: MEDIUM
A-Z Tobacco Inc d/b/a A-Z Tobacco and Vapor
Tobacco product adulterated and misbranded violation
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act  ·  Feb 14  ·  Impact: MEDIUM
Gorilla Vapes of East Brunswick
Tobacco product adulterated and misbranded violation
Why: Non-compliance with Family Smoking Prevention and Tobacco Control Act  ·  Feb 14  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →